Systemic thrombolysis for acute myocardial infarction in a renal transplant recipient.
This study describes the successful management of an acute myocardial infarction occurring in a renal transplant recipient with thrombolytic therapy. Although primary coronary angioplasty has been addressed as an alternative therapeutic approach, this approach raises concern for angiography-related contrast media renal toxicity. However, pharmacological therapy with thrombolytics is effective and relatively safe and should be considered as the first-choice treatment in today's clinical setting.
Tiberti
G
G
Division of Cardiology, Lecco Hospital, Italy.
Selva
A
A
Bana
G
G
Bossi
M
M
D000328:Adult; D015906:Angioplasty, Balloon, Coronary; D003287:Contrast Media / Q000009:adverse effects; D017023:Coronary Angiography / Q000009:adverse effects; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D007668:Kidney / Q000187:drug effects; D016030:Kidney Transplantation; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000628:therapy; D012449:Safety; D015912:Thrombolytic Therapy
D003287:Contrast Media; D005343:Fibrinolytic Agents